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Original Articles
The Association between Increased Use of Labor Induction
and Reduced Rate of Cesarean Delivery
James M. Nicholson, M.D., MSCE,1 Peter Cronholm, M.D., MSCE,1 Lisa C. Kellar, M.D.,2
Morghan H. Stenson, CNM=WHNP, MSN,3 and George A. Macones, M.D., MSCE4
Abstract
Aim: An association was recently reported between a low cesarean section delivery rate and a method of
obstetrical care that involved the frequent use of risk-guided prostaglandin-assisted preventive labor induction.
We sought to confirm this finding in a subsequent group of pregnant women.
Methods: A retrospective cohort study design was used to compare the outcomes of 100 consecutively delivered
women, who were exposed to the alternative method of care, with the outcomes of 300 randomly chosen women
who received standard management. The primary outcome was group cesarean delivery rate. Secondary out-
comes were rates of neonatal intensive care unit admission, low 1-minute Apgar score, low 5-minute Apgar
score, and major perineal trauma.
Results: Women exposed to the alternative method of obstetrical care had a higher induction rate (59% vs.
16.3%, p< 0.001), a more frequent use of prostaglandins for cervical ripening (32% vs. 13%, p< 0.001), and a
lower cesarean delivery rate (7% vs. 20.3%, p¼ 0.002). Exposed women did not experience higher rates of other
adverse birth outcomes.
Conclusions: Exposure to an alternative method of obstetrical care that used high levels of risk-driven
prostaglandin-assisted labor was again associated with two findings: a lower group cesarean delivery rate and
no increases in levels of other adverse birth outcomes. An adequately powered randomized controlled trial is
needed to further explore this alternative method of care.
Introduction
United States rates of cesarean delivery have risenevery year since 1997 and in 2006 reached an all time
high of 31.1%.1 Possible reasons for these recent increases
include changing patient demographics, medical-legal pres-
sures, and an increasing number of indications for cesarean
delivery.2–4 Despite calls from various sectors to slow or re-
verse these trends,5,6 there has been little success in develop-
ing methods of care that safely avoid cesarean delivery.6
Prevention of cesarean delivery is important because, as
compared with simple vaginal delivery, cesarean delivery is
associated with multiple adverse outcomes, including but not
limited to higher rates of major postpartum infection,7 in-
creased need for neonatal intensive care unit (NICU) admis-
sion,8 longer hospital length of stay for mother and baby,9
increased maternal mortality,10 and higher overall costs.9
Despite suggestions that elective primary cesarean delivery
could improve maternal perineal health,11,12 the long-term
benefits of this proposed intervention are unproven,13–15 and
the long-term risks of elective cesarean delivery have proba-
bly been minimized.16,17 Consequently, a method of care that
could safely prevent cesarean delivery is still being sought.
An association between a very low group cesarean delivery
rate (4%) and exposure to an alternative method of care in an
urban setting was recently described.18 This alternative
method of care is called the Active Management of Risk in
Pregnancy at Term (AMOR-IPAT). AMOR-IPAT begins with
the use of each woman’s constellation of prenatal risk factors
to estimate an upper limit of her optimal of delivery (UL-
OTD).19 Women who do not develop spontaneous labor by
their UL-OTD are offered preventive labor induction to de-
crease the possibility of one of two events: (1) that their fetus
will be too large to pass through thematernal pelvis or (2) that
the placental will be too old to support the fetus during labor.
Accordingly, AMOR-IPAT requires a high rate of preventive
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labor induction. In addition, because cervical ripening is re-
quired if labor induction is planned for a woman with an
unfavorable cervix (i.e., modified Bishop’s score 5), AMOR-
IPAT also involves a high rate of vaginal prostaglandin
medication use.18,20 The purpose of this investigation was to
see if the previously reported association between AMOR-
IPAT exposure and low cesarean delivery rates in an urban
setting could be replicated within the context of a second fully
detailed study.
Materials and Methods
As in the first AMOR-IPAT study,18 we employed a retro-
spective cohort study design to compare the outcomes of the
100 consecutively delivered women exposed to the AMOR-
IPAT method of care with the outcomes of 300 randomly
chosen women who received usual obstetrical care. All de-
liveries for this study occurred between April 2001 and
October 2002, and no deliveries that were included in the
original study were included in this study. AMOR-IPAT
exposure revolved around estimating the UL-OTD for each
exposed woman. For UL-OTD estimation, each woman’s
personal constellation of risk factors for cesarean delivery
was used to estimate the number of days before 41 weeks 0
days gestation she should deliver in order to minimize her
chances of developing either cephalopelvic disproportion or
uteroplacental insufficiency.18–20 A scoring sheet for UL-OTD
estimation is included as the Appendix. In order to minimize
the risk of neonatal pulmonary problems related to preventive
labor induction, confirmation of pregnancy dating with early
ultrasound and the use of 38weeks 0 days as the lower limit of
the optimal time of delivery (LL-OTD) were integral parts of
the AMOR-IPAT protocol. Once a woman’s final UL-OTD
was determined, the term period of her pregnancy was
managed so as to increase the likelihood that she delivered
before her ULOTD. If a woman developed spontaneous labor
before her UL-OTD, her labor and delivery were managed in
the usual manner. However, if spontaneous labor did not
develop by a week or so before her UL-OTD, she was sched-
uled for preventive labor induction so that she delivered
1–3 days before her UL-OTD. In addition, if a woman was
scheduled for a preventive induction but her cervix was not
favorable (i.e., modified cervical Bishop’s score 5,21 cervical
ripening was provided. Prostaglandin E2 (PGE2) (dinopros-
tone [Cervidil, Forest Laboratories, Inc., New York, NY]),
prostaglandin E1 (PGE1) (misoprostol [Cytotec, GD Searle
LLC, Chicago, IL], or a Foley bulb catheter (30–60mL) was
used, as needed, for this purpose. All women receiving pre-
ventive labor induction were counseled with regard to the
theoretical increased risk of cesarean delivery, and women
offered preventive labor induction prior to 39 weeks 0 days
gestation were counseled with regard to the theoretical in-
creased risk of NICU admission because of possible fetal lung
immaturity in the early term period of pregnancy.
In this study, women exposed to AMOR-IPAT received
their prenatal care from three different family medicine of-
fices. Women who received the standard of care, that is, the
nonexposed group, received their care from four obstetrical
clinic practices and three obstetrical faculty practices. Inclu-
sion criteria included singleton pregnancy, at least one pre-
natal visit with amaternity care provider from our institution,
and delivery after 37 weeks 3 days gestation. Exclusion cri-
teria included >2 previous cesarean deliveries, any other
transmural uterine surgery, HIV infection, history of major
pelvic injury, major fetal anomaly, or any other factor pre-
cluding a trial of labor.
Our method of selecting nonexposed women was similar to
the methods previously employed.18 The date of delivery of
each exposed woman was determined. For each exposed sub-
ject, a random numbers chart was used to identify a number
between 1 and 7. The number so selected was added to the
delivery date of the exposed subject to obtain a random date.
Next, a randomnumbers table was used to select three random
numbers between 1 and 60. Each number so selected was used
to randomly select control subjects by sequentially counting off
women in the labor and delivery log book of theHospital of the
University of Pennsylvania. The firstwoman, on or after each of
the three counts, who met the study’s inclusion and exclusion
criteriawas included in the study. If thewoman selected for any
given random date and number had already been selected as a
study subject, then the next eligible woman was selected.
We improved on our original study design in two ways.
First, we matched for parity status. Exposed nulliparous
woman (nulliparas) were matched with three nonexposed
nulliparas. Exposed multiparous women (multiparas) were
matched with three nonexposed multiparas. Exposed women
with a previous cesarean delivery Vagina birth after cesarean
(VBACs) were matched with three nonexposed VBACs. All
VBAC women had to be eligible for a trial of labor (e.g., no
history of>2 cesarean deliveries or classical incision). Second,
we excluded women who received their prenatal care from
maternal fetal medicine offices or high-risk clinics because
these women are generally thought to have higher levels of
prenatal risk than women who received their prenatal care
from either general obstetricians or family physicians. This
study was powered to test for a 60% reduction in cesarean
delivery rate with a standard rate of 20%, alpha¼ 0.05, and
beta¼ 0.80. The Institutional Review Board of the University
of Pennsylvania approved this investigation.
Detailed data concerning prenatal variables, intrapartum
events, and clinical outcomes were abstracted for each iden-
tified mother-baby pair using a validated data abstraction
process. The resulting data were then entered into an Access
database using a validated data entry process. At least 10% of
abstractions and 10% of entries were repeated as a quality
assurance procedure. Missing values were obtained by re-
checking hospital records or by contacting a woman’s pri-
mary maternity care provider. Data were analyzed using the
STATA Statistical Program (version 8, College Station, TX).
The Student’s t test and the Wilcoxon rank-sum test were
used to compare distributions of demographic variables, past
medical=surgical history details, and obstetrical risk factors
present in the two study groups. Univariate chi-square tests
were used to compare levels of various covariables and
rates of common intrapartum variables. Statistical signifi-
cance was determined by a p value 0.05. Time intervals for
the various stages of spontaneous labor, labor induction, and
delivery were determined and compared using Wilcoxon
rank-sum testing. These analyses were performed on both the
two main study groups and on the three parity groups pre-
viously described. Data relating to the timing of delivery,
mode of labor onset, and method of delivery were collated
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according to gestational age, collapsed into half-week sub-
strata, and encoded to enable graphic representation.
The strength of association between cesarean delivery and
a variety of covariates, including AMOR-IPAT exposure, was
initially determined using univariate chi-square analysis.
These associations were further assessed using stepwise
multiple logistic regression. Clinical problems developing
between 38 weeks 0 days gestation and delivery (including
preeclampsia, oligohydramnios, thick meconium passage at
rupture of membranes, and intrapartum fever) were excluded
from the final model because of concerns that theymight lie in
the causal chain between lack of delivery before the UL-OTD
and cesarean section. In order to more fully evaluate the as-
sociation between AMOR-IPAT exposure and cesarean de-
livery risk, however, additional models were developed that
included these variables.
To evaluate the possibility that AMOR-IPAT exposure
could have been associated with increased rates of various
adverse outcomes, risk differences for salient adverse birth
outcomes between the two groups were calculated using chi-
square analysis. Rates of salient birth outcomes were also
determined as a function of each of the three parity sub-
groups. Finally, a number needed to treat analysis was per-
formed to estimate the number of women who would need to
be exposed to the AMOR-IPAT method of care to prevent a
single cesarean section.
Table 1. Levels of Risk Factors by Study Group
Variable Exposed n¼ 100 Nonexposed n¼ 300 Risk ratio 95% CI p value
Demographics
Age, median, years 23 25.9 <0.00
Advanced age (35 years at delivery) 4% 10.3% 0.39 0.14-1.07 0.06
African American 81% 69.3% 1.17 1.03-1.32 0.03
Private medical insurance 38% 47.3% 0.80 0.61-1.06 0.13
Single marital status 82% 69.3% 1.18 1.05-1.33 0.01
Past medical history
Chronic hypertension 7% 2.3% 3.0 1.08-8.34 0.05
Asthma 20% 11.7% 1.71 1.04-2.83 0.04
Type I diabetes 0% 0.3% 0.00 – 1.00
Sickle cell trait 4% 5.7% 0.71 0.24-2.05 0.61
Cigarette use 22% 19.7% 1.12 0.72-1.73 0.67
Alcohol use 3% 3% 1.00 0.28-3.62 1.00
Past obstetric=gynecological history
Previous SABa 25% 25% 1.00
Previous TAB 31% 31.3% 0.99 0.71-1.39 1.00
Previous small infant (<6 lb 8 oz) 19% 12.7% 1.42 0.85-2.37 0.19
Previous large infant (>8 lb 8 oz) 11% 6% 1.83 0.90-3.75 0.12
Previous vacuum or forceps delivery 7% 4% 1.75 0.71-4.32 0.28c
Laboratory
1-hour 50 gm Glucola135 gm=dl 7% 11.3% 0.62 0.29-1.35 0.26
Hemoglobin (1st or 2nd trimester11) 26% 21% 1.24 0.83-1.84 0.33
Group B Streptococcus culture positive 32% 28% 1.14 0.81-1.60 0.45
Maternal habitus
Preconception weight, median 152 lb 149 lb 0.20b
Preconception weight>180 lb 30% 22.3% 1.34 0.93-1.94 0.14
Height, median 65 in 64 in 0.19b
Short stature (62 inches) 22% 22.3% 0.99 0.64-1.51 1.00
Preconception BMI, mean (kg=m2) 26.6 25.0 0.26b
High BMI (30m=kg2) 26.3% 25.2% 1.04 0.71-1.53 0.83
Index pregnancy
Nulliparous status 34% 34% 1.00 0.73-1.37 1.00
Multiparous (all) 66% 66% 1.00 0.85-1.18 1.00
Multiparous without cesarean 58% 58% 1.00 0.82-1.21 1.00
Multiparous with previous cesarean 8% 8% 1.00 0.46-2.15 1.00
Previous cesarean, previous vaginal birth 62.5% 37.5% 1.67 0.79-3.51 0.22
Excess weight gain (30 lb) 47% 53.7% 0.88 0.69-1.11 0.25
Gestational diabetes 3% 2.3% 1.29 0.34-4.88 0.72
Elevated AFP 0% 2.7% 0.00 – 0.21
Weight gain during pregnancy, median 29 lb 30 lb 0.00 – 0.19
Excess weight gain (30 lb) 47% 53.7% 0.88 0.69-1.11 0.25
aSAB, spontaneous abortion; TAB, therapeutic abortion; BMI, body mass index; AFP, alpha-feto protein.
bCalculated with Mann Whitney rank-sum test.
cCalculated for patients with at least one previous birth (vaginal and=or previous cesarean).
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Results
Table 1 shows levels of prenatal risk factors present in the
study groups. Although distributions of age, race, ethnicity,
marital status, and prepregnancy hypertension were present
at statistically different levels, the two groups of this study
appeared more similar than the two groups in our first urban
study.18 Table 2 presents levels of intrapartum factors in
the two study groups. As in the initial study, the overall
labor induction rate was significantly higher (60% vs. 16%,
p< 0.001), the percentage of women receiving cervical ripen-
ing was significantly higher (21% vs. 13%, p< 0.001), and the
average gestational age of deliverywas significantly lower (38
weeks 4 days vs. 39 weeks 6 days, p< 0.001) in the AMOR-
IPAT-exposed group compared with the nonexposed group.
The average cervical Bishop’s score on admission, the rate of
spontaneous rupture of membranes prior to admission, and
the rate of thick meconium at rupture of membranes were all
significantly lower in the exposed group.
Table 3 presents information about labor induction in the
study groups. The preventive labor induction rate was sig-
nificantly more frequent in the exposed group (52% vs. 2%,
p< 0.001), and the reasons for both indicated and elective
induction were different in the exposed group as compared
with the nonexposed group. The most common reasons for
labor induction in the AMOR-IPAT-exposed group were im-
pending cephalopelvic disproportion and impending uter-
oplacental insufficiency.
The exposed group had a longer mean interval between
admission and delivery (15.3 hours vs. 9.00 hours, p< 0.001).
This was largely because of a longer mean interval between
admission and the onset of labor (7.36 hours vs. 2.75 hours,
p< 0.001). For women in the exposed nulliparous group,
compared with nulliparous women in the nonexposed group,
the median length of the first stage of labor was 522 minutes
vs. 418 minutes ( p¼ 0.18), and the median length of the sec-
ond stage was 49 vs. 46 minutes ( p¼ 0.80). For women in the
exposed multiparous group, compared with multiparous
Table 2. Levels of Intrapartum Variables=Factors by Study Group
Variable Exposed n¼ 100 Nonexposed n¼ 300 Risk ratio 95% CI p value
Status on admission
Gestational age at delivery, all (median) 38.6 weeks 39.9 weeks <0.001a
Gestational age on admission,
nullipara (median)
38.7 weeks 40.0 weeks <0.001a
Gestational age on admission,
multipara (median)
38.4 weeks 39.9 weeks <0.001a
Gestational age on admission previous
cesarean (median)
38.5 weeks 39.6 weeks 0.15a
Post dates delivery (>41 weeks) 9% 16% 0.56 0.29-1.10 0.10
Ruptured membranes on admission 11% 28.3% 0.39 0.22-0.70 0.004
Initial Bishop’s score (mean) 3.5 4.9 <0.001a
Initial Bishop’s score5 88% 51.3% 1.71 1.50-1.96 <0.001a
Mean arterial pressure (MAP, mean) 87.2mmHg 89.5mmHg 0.02a
Mean arterial pressure (MAP) 105mm Hg 5% 6.3% 0.78 0.30-2.06 0.81a
Vertex presentation 99% 98% 1.01 0.98-1.04 0.69
Intrapartum interventions
Induction of labor 59% 16.3% 3.61 2.67-4.89 <0.001
Augmentation of labor 26% 50.7% 0.51 0.37-0.73 <0.001
Prostaglandin use (any) 32% 13.0% 2.46 1.64-3.71 <0.001
Misoprostol (PGE1) 13% 11% 1.18 0.65-2.15 0.59
Dinoprostone (PGE2) 21% 1.3% 15.75 5.54-44.78 <0.001
Use of pitocin (any) 74% 51% 1.45 1.24-1.70 <0.001
Artificial rupture of membranes 50% 28.3% 1.76 1.35-2.30 <0.001
Epidural analgesia, overall 67% 80.3% 0.83 0.72-0.97 0.009
Epidural analgesia, nullipara 76.5% (26=34) 88.2% (90=102) 0.91 0.76-1.10 0.27
Epidural analgesia, multipara,
no previous cesarean
56.9% (33=58) 73.0% (127=174) 0.87 0.71-1.06 0.10
Epidural analgesia, multipara,
previous cesarean
100% (8=8) 100% (24=24) – – –
Placement of internal electrode 34% 33.3% 1.02 0.74-1.40 0.90
Placement of IUPCb 12% 30% 0.40 0.23-0.70 <0.001
Episiotomy (second degree) 0% 11% 0.00 – <0.001
Use of vacuum or forceps 16% 11.3% 1.41 0.82-2.44 0.23
Intrapartum findings
Thick meconium at ROM 4% 16% 0.25 0.92-0.68 0.001
Fetal intolerance to laborc 3% 12% 0.25 0.08-0.79 0.006
Maternal Fever (Tmax> 100.5) 6% 5.3% 1.12 0.45-2.80 0.80
aMann Whitney rank-sum test.
bIUPC, intra-uterine pressure catheter; ROM, rupture of membranes; Tmax, maximum temperature.
cRepetitive late decelerations.
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women in the nonexposed group, the median length of the
first stage of labor was 285 minutes vs. 260 minutes ( p¼ 0.15),
and the median length of the second stage was 15 minutes vs.
16 minutes ( p¼ 0.95). The data concerning length of first-
stage and second-stage duration were potentially impacted
by right censoring in the nonexposed groups related to higher
cesarean delivery use in these groups. Finally, because of the
lower cesarean delivery rates, all exposed parity groups had a
shorter median postdelivery hospital stay than the corre-
sponding nonexposed group. Overall, women exposed to
AMOR-IPAT and their babies had significantly shorter mean
lengths of total hospital stay (63.1 hours vs. 66.8 hours,
p¼ 0.38; 55.0 hours vs. 63.2 hours, p< 0.001, respectively).
Figure 1A demonstrates graphically that as a function of
gestational age at the time of delivery, exposed women
delivered earlier in the term period than did nonexposed
women. Not all exposed women agreed to preventive
induction on or before 41 weeks 0 days of gestation, and 8
exposed women delivered after 41 weeks 0 days of gestation.
Figure 1B demonstrates that exposed women experienced
induction of labor more frequently and at earlier gestational
ages than did nonexposed women.
Table 4 presents information related to cesarean delivery in
the study groups. The exposed group had a significantly
lower overall cesarean delivery rate (7% vs. 20.3%, p¼ 0.002)
and a significantly lower cesarean delivery in the multiparous
group without history of previous cesarean delivery (0% vs.
10.9%, p¼ 0.005). Exposed cesarean delivery rates trended
lower in the nulliparous group and in the VBAC group.When
all women with previous cesarean delivery were excluded,
there was a significantly lower cesarean delivery rate in the
AMOR-IPAT-exposed group (5.4% vs. 14.3%, OR 0.34, 95%CI
0.10–0.91, p¼ 0.02). Despite 11 elective cesarean deliveries in
the nonexposed group (1 elective cesarean delivery for pre-
sumed fetal macrosomia and 10 elective repeat cesarean de-
liveries), the nonexposed group had a significantly greater
number of cesarean deliveries for failure to progress (8.7% vs.
2%, p¼ 0.02). The cesarean delivery rate remained signifi-
cantly lower in the exposed group even if the elective cesarean
deliveries were excluded from the nonexposed group: 7%
(7=100) vs. 17.3% (50=289), RR 0.40, p¼ 0.012. Figure 1C
demonstrates the mode of delivery in the two study groups as
a function of gestational age at delivery.
Table 5 provides information from the final logistic re-
gression modeling of the association between exposure and
cesarean delivery. The final model included seven risk factors:
AMOR-IPAT status (exposed vs. nonexposed), parity group
(nullipara,multipara, or VBAC), cocaine abuse, alcohol abuse,
insurance status (Medicaid vs. private insurance), advanced
maternal age (<35 years of age or 35 years of age at deliv-
ery), and epidural analgesia use. Adjustment for these im-
portant covariates did not alter the magnitude of association
between AMOR-IPAT exposure and lower cesarean delivery
rate. There was also no significant impact on this association
when clinical problems that developed between 38 weeks
0 days gestation and delivery (e.g., maternal fever, pre-
eclampsia, oligohydramnios, and thick meconium at rupture
of membranes) were added to the model (data not shown).
Table 6 lists important clinical outcomes other than cesar-
ean section that occurred in the two study groups. Rates of
major perineal trauma, thick meconium at rupture of mem-
branes, and repetitive late decelerations were low enough in
the AMOR-IPAT-exposed group to indicate that it is unlikely
that AMOR-IPAT exposure could have been associated with
increased rates of these outcomes. Rates of assisted vaginal
delivery were higher in the exposed group but did not reach
Table 3. Induction of Labor Information: Overall Rates and Indicationsa
Induction of labor informationa Exposed n¼ 100 Nonexposed n¼ 300 Risk ratio 95% CI p value
Induction of labor rate, overalla 59% 16.3% 3.75 2.77-5.09 <0.001
Indicated induction 12% 13.7% 0.88 0.48-1.60 0.67
Preventive induction 43% 1.7% 17.6 8.6-36.0 <0.001
Elective inductionb 4% 1.0%
Reasons for indicated induction
Severe preeclampsia 1% 3.3% 0.3 0.04-2.31 0.22
Oligohydramnios=IUGR 6% 3.7% 1.64 0.62-4.31 0.32
>41 weeks 5% 4.3% 1.15 0.42-3.16 0.78
>42 weeks 0% 1.0% 0 – 0.32
Gestational diabetes 0% 0.7% 0 – 0.41
Chronic hypertension 0% 0.3% 0 – 0.85
Acute cholestasis 0% 0.3% 0 – 0.85
Polyhydramnios 0% 0% – – –
Nonreassuring antenatal testing 0% 0% – – –
Reasons for preventive induction
Impending preeclampsia 5% 0% – – <0.001
Impending cephalopelvic disproportion 27% 0.67% 40.5 9.8-167 <0.001
Impending uteroplacental insufficiency 8% 0.33% 24.0 3.04-189 <0.001
Gestational diabetes 0% 0.67% 0 – 0.41
History of precipitous labor 2% 0% – – 0.05
Unstable fetal liec 1% 0% – – 0.08
aAll rates entire study group as denominator.
bElective reasons—convenience, patient request, frequent false labor visits.
cInduction immediately following successful repeat external cephalic version.
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statistical significance (16% vs. 11.3%, p¼ 0.23). The only
outcome that was present at significantly higher rates fol-
lowing AMOR-IPAT exposure was birth weight <6 lb 8 oz
(32% vs. 18.3%, p¼ 0.005). Rates of very small infants (birth
weight<5 lb 8 oz) trended higher after exposure (6% vs. 2.3%,
p¼ 0.10), but none of the AMOR-IPAT-exposed infants who
weighed <6 lb 8 oz at birth or were delivered following labor
induction required NICU admission. In addition, none of the
13 infants in the exposed group delivered after labor induc-
tion prior to 39weeks 0 days of gestation developed transcient
tachypnea of the newborn, required therapy for hyperbilir-
ubinemia, or were admitted to the NICU. In all parity groups,
women in the exposed study group were significantly more
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FIG. 1. (A) Distribution of timing of delivery as a function of gestational age, by study groups. (B) Spontaneous vs. induced
labor as a function of gestational age, by study group. (C) Vaginal vs. cesarean delivery as a function of gestational age, by
study group.
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women: 50% vs. 0%, p< 0.001; multiparous women without
history of cesarean delivery: 50% vs. 2.9%, p< 0.001; multip-
arous women with history of cesarean delivery: 75% vs. 4.2%,
p< 0.001). Except for a nonstatistically significant upward
trend in third-degree or fourth-degree perineal injury in
exposed nulliparous group (14.7% [5=34] vs. 7.8% [8=102]),
every other major outcome in every parity group was similiar
or was lower in the exposed group compared with the non-
exposed group (data not shown) (Table 7). Finally, the num-
ber of women who needed to be exposed to AMOR-IPAT
in order to prevent one cesarean delivery was calculated to
be 7.5.
Discussion
This article corroborates the association recently reported
between exposure to AMOR-IPAT, with its high group labor
induction rate and high group prostaglandin cervical ripening
rate, and a lower group cesarean delivery rate. As in the first
study,18 this association was statistically significant after ad-
justment for possible confounding variables. Rates of other
adverse birth outcomes were either lower or unchanged in the
AMOR-IPAT exposed study group compared with the non-
exposed group.
Most previous investigations have reported an association
between indicated labor induction and increased use of
cesarean delivery.22–26 However, AMOR-IPAT uses labor
Table 4. Cesarean Delivery Overall Rates and Indicationsa
Cesarean delivery informationa Exposed n¼ 100 Nonexposed n¼ 300 Risk ratio 95% CI p value
Overall cesarean delivery rate 7% 20.3% 0.34 0.16-0.73 0.002
Cesarean rate by different subgroups
Nulliparousb 14.7% (5=34) 26.5% (27=102) 0.56 0.23-1.33 0.24
Multiparous, no previous cesareanb 0% (0=58) 10.9% (19=174) 0 – 0.005
Multiparous with history
of previous cesareanb
25% (2=8) 62.5% (15=24) 0.4 0.12-1.38 0.11
Multiparous, history of cesarean,
no prior vaginal birth
33.3% (1=3) 80% (12=15) 0.42 0.08-2.11 0.10
Multiparous, history of cesarean,
prior vaginal birth
20% (1=5) 33.3% (3=9) 0.60 0.08-4.35 0.60
Multiparous, history of previous
cesarean and with trial of laborb
25% (2=8) 35.7% (5=14) 0.71 0.19-2.69 0.60
All women without history of
previous cesarean
5.4% (5=92) 16.7% (46=276) 0.33 0.13-0.80 0.007
Indications for cesarean delivery
Fetal intolerance of labor 4% 6.3% 0.5 0.15-1.66 0.31
Failure to progress 3% 8.0-% 0.23 0.56-0.96 0.02
Malpresentation (breech) 0% 1.7% 0 – 0.34
Active herpes infection 0% 0.7% 0 – 1.00
Elective repeat cesarean 0% 3.3% 0 – 0.07
Elective cesarean for macrosomia 0% 0.33% – – –
Cesarean delivery by mode of labor onset
Noninduced onset (all)b 2.4% (1=41) 18.3% (32=238) 0.18 0.03-1.29 0.04
Spontaneous labor, no ROM on
admission, no augmentationb
10% (1=10) 3.6% (2=56) 2.8 0.28-28.0 0.37
Spontaneous labor, no ROM on
admission, with augmentationb
0% (0=20) 16.0% (16=100) 0 – 0.05
ROM on admission, spontaneous
labor, no augmentationb
0% (0=5) 13.8% (4=29) 0 – 0.38
ROM on admission, with augmentationb 0% (0=6) 18.9% (10=53) 0 – 0.24
Induced onset (all)b 10.2% (6=59) 30.6% (15=49) 0.33 0.14-0.79 0.008
Indicated induction of laborb 16.7% (2=12) 36.7% (15=41) 0.46 0.12-1.72 0.19
Elective induction of laborb 8.5% (4=47) 0% (0=8) 0 – 0.39
Elective repeat cesareanb 0% (0=0) 100% (13=13) 0 – –
aWhen not specified, rates are based on entire study group.
bRates calculated based on substrata.
Table 5. Logistic Regression Modeling of AMOR-IPAT








AMOR-IPAT exposure 0.29* 0.29* (0.12-0.73)
Nulliparity 1.00* 1.00* –
Multiparity 0.29* 0.25* (0.12-0.50)
Previous cesarean section 3.68* 3.31* (1.39-7.91)
Epidural analgesia 12.27* 8.41* (1.84-38.41)
Alcohol use 2.53 6.62* (1.50-29.2)
Medicaid insurance 1.37 1.70 (0.91-3.16)
Cocaine use 6.85* 5.23 (0.72-38.17)
Age 35 2.48* 2.09 (0.91-3.16)
aListed according to decreasing significance within the final
logistic model.
*Statistically significant ( p< 0.05).
WELL-TIMED INDUCTIONS MAY PREVENT CESAREAN SECTIONS 1753
induction primarily in a preventive mode rather than in re-
sponse to standard indications. In addition, published studies
of AMOR-IPAT evaluate the impact of labor induction from a
practice-based perspective rather than a labor onset-based
perspective.18–20 To support this analytical perspective, a
practice-based statistical approach is routinely used to mea-
sure U.S. national and state cesarean delivery rates.1 In con-
trast to the the 2006 national cesarean delivery rate of 31.1%,
however, all published retrospective studies involving
AMOR-IPAT have reported cesarean delivery rates of <11%
in the exposed groups.18,20,26–30
On the surface, these findings are at odds with multiple
studies that have reported an association between labor in-
duction and an increased risk of cesarean delivery.22–26
However, the first AMOR-IPAT article18 described a variety
of theoretical problems with previous studies, including both
confounding by indication and problems with study design.
Important questions have not been asked or answered: (1) In
retrospective studies, are the higher rates of cesarean delivery
in women who are induced using standard obstetrical pro-
tocols due to the induction event per se, or are they due to the
reasons that the inductions were initiated? (2) Should retro-
spective study group designation be determined by mode of
labor onset (spontaneous labor vs. induction) or by practice-
based criteria (groupAwith a lower rate of labor induction vs.
group Bwith a higher rate of labor induction)? A recent article
suggested that the association between induction and cesar-
ean delivery vanished after adjustment for potential con-
founding variables.27 In addition, a recent meta-analysis of
randomized prospective studies28 determined that the use of
labor induction to encourage delivery at 41 weeks of gesta-
tion, compared with expectant management until 42 weeks
gestation, modestly decreased cesarean delivery risk. Both the
first AMOR-IPAT article and this investigation suggest that
Table 6. Major Outcomes and Risk Differences for Outcomes Based on AMOR-IPAT







difference 95% CI p value
Maternal—Delivery
3rd or 4th degree perineal injury, all 5% 5.3% 0.003 (0.05)-(0.05) 1.0
3rd or 4th degree tear in women
with vaginal delivery only
5.4% (5=93) 6.7% (16=239) 0.013 (0.07)-(0.04) 0.66
3rd or 4th degree tear in women
without previous cesarean delivery
5.4% (5=92) 5.8% (17=276) 0.004 (0.06)-(2.49) 0.90
Assisted vaginal delivery, all 16% 11.3% 0.05 (0.03)-(0.13) 0.22
Assisted vaginal delivery,
vaginal delivery only
17.2% (16=93) 13.0% (31=239) 0.04 (0.04)-(0.13) 0.38
Assisted vaginal delivery in women
without previous cesarean delivery
16.3% (15=92) 12.0% (33=276) 0.04 (0.04)-(0.13) 0.28
Estimated blood loss, all 356mL 245 445mL (260) – – <0.001
Estimated blood loss, vaginal
delivery women only
312mL 188 344mL 124 – – 0.001
Excess blood loss (>500mL), all 19% 36% 0.17 (0.26)-(0.08) 0.002
Excess blood loss (>500mL),
vaginal delivery women only
12.9% 20.1% 0.07 (0.16)-(0.01) 0.15
Maternal–Postpartum
Maternal fever (>100.48F) 3% 6% 0.03 (0.07)-(0.01) 0.31
Postpartum anemia (Hgb<8.0 g=dL) 10% 8.3% 0.02 (0.05)-(0.08) 0.68
Flux in hemoglobin with delivery 1.24 g 0.94 1.48 g 1.03 – – 0.06
Neonatal
NICU admission, all 7% 9% 0.02 (0.08)-(0.04) 0.68
NICU Admission in women
without previous cesarean delivery
6.5% 8.7% 0.02 (0.08)-(0.04) 0.51
Sepsis, suspected or actual 5% 5.7% 0.01 (0.01)-(0.04) 1.00
Meconium aspiration 1% 3.7% 0.03 (0.06)-(0.002) 0.31
Cephalohematoma 2% 4% 0.02 (0.06)-(0.02) 0.53
Birth weight 3167 g 447 3394 g 476 – – <0.001
Large (>8 lb 7 oz) 7% 19.3% 0.13 (0.19)-(0.06) 0.003
Small (<6 lb 8 oz) 32%b 18.3% 0.14 (0.04)-(0.24) 0.004
Very Small (<5 lb 8 oz) 6%c 2.3% 0.04 (0.01)-(0.09) 0.10
Head circumference 33.6 cm 1.6 34.0 cm 1.8 0.02
Apgar 1< 7 10% 13.7% 0.04 (0.11)-(0.03) 0.39
Apgar 1< 4 4% 3.3% 0.01 (0.04)-(0.05) 0.76
Apgar 5< 7 1% 0.7% 0.003 (0.02)-(0.02) 1.00
Apgar 5< 4 1% 0.3% 0.01 (0.01)-(0.03) 0.44
aCalculated with the Mann Whitney rank-sum test.
bOf the 17 of these infants delivered following induction, none required NICU admission.
cOf the 5 of these infants delivered following induction, none required NICU admission.
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the careful use of preventive labor induction prior to 41 weeks
of gestation might further reduce rates of adverse birth out-
comes.
Several recent studies have suggested a continuous in-
crease in the risk of adverse birth outcomes as a function of
increasing gestational age during the term period of preg-
nancy.29–33 The higher induction of labor rate in the exposed
group of this study necessarily lowered its average gestational
age. Lower gestational age may favorably impact the mode of
delivery in two important ways. First, because fetal weight
increases continuously during the term period,34 earlier de-
livery through AMOR-IPAT may have reduced cesarean de-
livery for failure to progress (FTP) by encouraging labor when
the fetus was mature but relatively small. A lower median
birth weight and a lower rate of macrosomia (birth weight
>4000 g) were noted in the exposed group compared with the
nonexposed group. Second, because placental function de-
creases continuously during the term period,34 earlier deliv-
ery through AMOR-IPAT may have reduced cesarean
delivery for uteroplacental insufficiency by encouraging labor
at the time of optimal placental functioning. Lower rates of
both thick meconium at rupture of membranes and fetal in-
tolerance of labor (severe variable and repetitive late decel-
erations) were noted in the exposed group compared with the
nonexposed group. AMOR-IPAT employed the concept that
certain risk factors accelerate fetal growth and certain risk
factors accelerate placental senescence.19 Hence, AMOR-
IPAT-exposed women with risk factors were encouraged to
deliver earlier in the term period than exposed women
without risk factors, and the timing of induction was directly
related to the quantity of any given exposed patient’s cumu-
lative risk.
We acknowledge that this study has a number of limita-
tions. First, it was retrospective and therefore potentially
influenced by unknown confounders. Although logistic re-
gression demonstrated that adjustment for known con-
founding variables did not alter the strength of association
between exposure and cesarean delivery rate reduction, it is
Table 7. Labor Onset and Outcome Information According to Parity Groupa
Variable Exposed Nonexposed Risk ratio 95% CI p value
Labor onset
Indicated induction
Nullipara 11.8% (4=34) 18.6% (19=102) 0.63 0.23-1.73 0.36
Multipara without previous cesarean 8.6% (5=58) 10.9% (19=174) 0.82 0.36-1.84 0.80
Multipara with previous cesarean 37.5% (3=8) 12.5% (3=24) 3.0 0.75-12.0 0.12
Preventive induction
Nullipara 41.2% (14=34) 2.0% (2=102) 21 5.0-87.7 <0.001
Multipara without previous cesarean 50% (29=58) 3.4% (6=174) 14.5 6.3-33.2 <0.001
Multipara with previous cesarean 50% (4=8) 0% (0=24) – – <0.001
Elective cesarean delivery
Nullipara 0.0% (0=34) 2.0% (2=102) 0.0 – 1.00
Multipara without previous cesarean 0.0% (0=58) 1.2% (2=174) 0.0 – 1.00
Multipara with previous cesarean 0.0% (0=8) 41.7% (10=24) 0.0 – 0.04
Prostaglandin E2 use
Nullipara 47.1% (16=34) 1.0% (1=102) 48 6.61-348.57 <0.001
Multipara without previous cesarean 3.5% (2=58) 1.2% (2=174) 3.0 0.43-20.82 0.26
Multipara with previous cesarean 37.5% (3=8) 4.2% (1=24) 9.0 1.08-74.76 0.04
Major outcomes
3rd or 4th degree perineal injury
Nullipara 14.7% (5=34) 7.8% (8=102) 1.88 0.66-5.35 0.31
Multipara without previous cesarean 0.0% (0=58) 4.6% (8=174) 0.0 – 0.21
Multipara with previous cesarean 0.0% (0=8) 0.0% (0=24) – – –
NICU admission (overall)
Nullipara 8.8% (3=34) 12.8% (13=102) 0.69 0.21-2.28 0.76
Multipara without previous cesarean 5.2% (3=58) 6.3% (11=174) 0.82 0.24-2.83 1.00
Multipara with previous cesarean 12.5% (1=8) 12.5% (3=24) 1.0 0.12-8.31 1.00
Thick meconium passage
Nullipara 2.9% (1=34) 17.7% (18=102) 0.17 0.23-1.20 0.04
Multipara without previous cesarean 5.2% (3=58) 16.1% (28=174) 0.32 0.10-1.02 0.04
Multipara with previous cesarean 0.0% (0=8) 8.3% (2=24) 0.00 – 0.40
Apgar 1< 7
Nullipara 8.8% (3=34) 17.7% (18=102) 0.50 0.16-1.59 0.28
Multipara without previous cesarean 12.1% (7=58) 12.1% (21=174) 1.00 0.45-2.23 1.00
Multipara with previous cesarean 0.0% (0=8) 8.3% (2=24) 0 – 0.40
Apgar 5< 4
Nullipara 2.9% (1=34)b 0% (0=102) – – 0.25
Multipara without previous cesarean 0% (0=58) 1% (1=174)b 0 – 1.00
Multipara with previous cesarean 0% (0=8) 0% (0=24) – – –
aCalculated with the Mann Whitney rank-sum test.
bAssociated with spontaneous labor onset rather than induction of labor.
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possible that hidden confounders were present. Second, this
study occurred at a single quaternary care teaching institution
with primarily African American women, and it is unclear if
our results are generalizable to other types of institutions,
patient populations, or geographic areas. However, a large
retrospective study (n¼ 1869) describing the association be-
tween AMOR-IPAT exposure and a very low cesarean de-
livery rate (5.3%) was published recently,20 and that study
involved a rural nonteaching secondary hospital and a pri-
marily Caucasian population. Third, the difference in the
specialty of providers in the exposed and nonexposed groups
of this study raises the possibility of selection bias, informa-
tion bias, and differences in practice style, including threshold
for cesarean delivery. It is unlikely, however, that the major
findings of this study could be entirely explained by these
factors. The decision to perform cesarean delivery in this
study’s population was always made by obstetrician spe-
cialists and not by family physicians. In addition, cesarean
delivery rates as low as reported in this article have not been
reported recently from urban family practice settings. Finally,
the study was not powered to evaluate the association be-
tween AMOR-IPAT exposure and infrequent adverse out-
comes, such as neonatal hyaline membrane disease,
meconium aspiration syndrome, neonatal mortality, or ma-
ternal mortality. There were no apparent trends or near mis-
ses in the outcome data suggesting that maternal or neonatal
outcomes would have been less favorable had the study been
larger.
The benefit of the AMOR-IPAT approach may lie in the
finding that in both this study and the previous urban study,
the cesarean delivery rates declined with exposure in both the
induced labor subgroup and the spontaneous labor subgroup.
AMOR-IPAT-exposed women, especially those with in-
creased risk, were usually induced prior to their due date.
This led to labor that occurred at a time when there was a
reduced likelihood that patient risk factors had transformed
into an indication for cesarean delivery. Additionally, because
many exposed women with risk were induced, the exposed
women who did develop spontaneous labor carried, on av-
erage, lower levels of risk into labor than did the nonexposed
women who developed spontaneous labor. Despite the find-
ing that cesarean delivery occurred at higher rates in the
exposed=induced subgroup compared with the exposed=
spontaneous labor subgroup, the greater use of induction, in a
preventive mode, was associated with a lower cesarean de-
livery in both exposed subgroups compared with the corre-
sponding nonexposed subgroup. This may have led to the
significant overall reduction in group cesarean delivery rate.
As noted in our previous study, the full benefit of higher use
of preventive induction in retrospective studies can be seen
only if a treatment group perspective, rather than a mode of
labor onset perspective, is taken.
AMOR-IPAT has been widely challenged for not routinely
performing amniocentesis prior to preventive labor induction
in the 38th week of gestation. However, the use of AMOR-
IPAT in the setting of a randomized controlled trial was re-
ported recently, and with AMOR-IPAT exposure, the rate of
NICU admission was significantly lower than in the group
that was not exposed.30 In addition, all other previous retro-
spective studies of AMOR-IPAT have found either a lower or
an unchanged rate of NICU admission following AMOR-
IPAT exposure.18,20 In this study and in the randomized
clinical trial,35 the rate of NICU admission among infants de-
livered following preventive labor induction within the 38th
week of gestation has been unusually low. From the stand-
point of safely, however, it is important to note that the use of
preventive labor induction in the 38th week of gestation
probably requires both the use of AMOR-IPAT risk scoring to
justify early term labor induction and solid ultrasound-based
dating.
This study confirms our previous finding that exposure to
AMOR-IPAT, with its high rates of cervical ripening and
labor induction rate, was associated with a significantly
lower group cesarean delivery rate. As in our previous study,
rates of other major adverse birth outcomes were not in-
creased following exposure to AMOR-IPAT. Hence, AMOR-
IPAT may represent a strategy that provides for the safe
reduction of group cesarean delivery rates. Adequately
powered multisite prospective randomized trials are needed
to study the impact of AMOR-IPAT on major pregnancy
outcomes.
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Appendix: UL-OTD Scoring Sheet
A. Uteroplacental factors: Odds ratio Time units
History of chronic hypertension 1.8 6 days __________
Gestational diabetes 1.8 6 days __________
Insulin-dependent diabetes 2.4 10 days __________
Sickle cell trait 1.5 3 days __________
Elevated AFP 1.4 3 days __________
Cigarette use 1.3 2 days __________
Size<dates (3 cm) 1.6 4 days __________
Advanced age (35 years at delivery) 1.8 6 days __________
Anemia (1st trimester 10.0) 1.6 4 days __________
Total UPI time units
UL-OTD-upi (utero-placental insufficiency)¼ (41 weeks total UPI time units)¼
B. Cephalopelvic factors: Odds ratio Time units
Elevated BMI (30) 1.3 2 days __________
Short stature (62 inches) 1.8 6 days __________
Excess weight gain (30 lbs) 1.8 6 days __________
Size>dates (3 cm) 1.7 4 days __________
Gestational diabetes 1.8 6 days __________
Type 1 diabetes 2.4 10 days __________
History of vacuum=forceps 2.2 9 days __________
Previous macrosomia (4000 g) 2.0 7 days __________
Total CPD time units
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